133 related articles for article (PubMed ID: 6585680)
1. Circulating immune complexes in patients with lymphomas and leukemias.
Patel GV; Gopal R; Nadkarni JJ
Neoplasma; 1984; 31(2):197-202. PubMed ID: 6585680
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavorable prognosis.
Carpentier NA; Lange GT; Fiere DM; Fournie GJ; Lambert PH; Miescher PA
J Clin Invest; 1977 Oct; 60(4):874-84. PubMed ID: 268330
[TBL] [Abstract][Full Text] [Related]
3. Circulating immune complexes in patients with melanoma.
Sztaba-Kania M; Jassem J; Piskorzyńska M; Kondrat W
Neoplasma; 1981; 28(4):491-6. PubMed ID: 7027060
[TBL] [Abstract][Full Text] [Related]
4. [Circulating immune complexes in human leukemias].
Carpentier NA; Zubler RH; Lange GT; Lambert PH; Miescher PA
Schweiz Med Wochenschr; 1976 Oct; 106(40):1363-4. PubMed ID: 1070156
[TBL] [Abstract][Full Text] [Related]
5. [Circulating immune complexes in patients with lymphoproliferative and myeloproliferative diseases].
Loni C; Ricci S; Azzarà A; Bertoncini G
Quad Sclavo Diagn; 1984 Jun; 20(2):193-202. PubMed ID: 6441963
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of circulating immune complexes in hemolymphopathies].
Delsignore R; Baroni MC; Mineo F; Crotti G; Butturini U
G Clin Med; 1984; 65(3-4):157-62. PubMed ID: 6588012
[No Abstract] [Full Text] [Related]
7. [Appearance of circulating immune complexes in patients with Hodgkin's disease and the etiology of this disease].
Dziewulska-Bokiniec A; Sztaba-Kania M
Wiad Lek; 1992 Oct; 45(19-20):740-3. PubMed ID: 1296377
[TBL] [Abstract][Full Text] [Related]
8. Anti--DNA antibodies in patients with leukemia and lymphoma.
Izui S; Lambert PH; Carpentier NA; Miescher PA
Schweiz Med Wochenschr; 1976 Oct; 106(40):1377-8. PubMed ID: 1087460
[TBL] [Abstract][Full Text] [Related]
9. Presence of complement-fixing antibodies against antigens of Gross virus-induced rat lymphoma and normal rat thymus in sera of patients with some forms of malignancies.
Simkovic D; Chorváth B; Hlubinová K; Valentová N; Stevonková J; Babusíková O; Simkovicová M
Neoplasma; 1977; 24(4):357-63. PubMed ID: 269322
[TBL] [Abstract][Full Text] [Related]
10. Antigens and circulating immune complexes related to the primate retroviral glycoprotein SiSVgp70. Indicators of early mortality in human acute leukemias and chronic myelogenous leukemias in blast crisis.
Hehlmann R; Erfle V; Schetters H; Luz A; Rohmer H; Schreiber MA; Pralle H; Essers U; Weber W
Cancer; 1984 Dec; 54(12):2927-35. PubMed ID: 6093985
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
12. Studies on Paul-Bunnell (P-B) antigen-antibody system. II. P-B antigens in extracts of lymphoma-leukemia spleens and pathologic sera.
Masaki M; Kano K; Merrick JM; Milgrom F
J Immunol; 1981 Jul; 127(1):5-8. PubMed ID: 6972412
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
Rossen RD; Crane MM; Morgan AC; Giannini EH; Giovanella BC; Stehlin JS; Twomey JJ; Hersh EM
Cancer Res; 1983 Jan; 43(1):422-9. PubMed ID: 6600161
[TBL] [Abstract][Full Text] [Related]
14. Paul-Bunnell antigen in lymphoma and leukemia spleens.
Kano K; Fjelde A; Milgrom F
J Immunol; 1977 Sep; 119(3):945-9. PubMed ID: 268381
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM
Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841
[TBL] [Abstract][Full Text] [Related]
16. Association of circulating immune complexes with cytogenetic abnormalities but not with prognosis in acute nonlymphocytic leukemia.
Crane MM; Rossen RD; McCredie KB; Trujillo JM
Cancer Res; 1984 Jul; 44(7):3125-31. PubMed ID: 6609770
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of circulating immune complexes in lymphomas and leukemias using two different assays.
Patel GV; Gopal R; Nadkarni JJ
Cancer Immunol Immunother; 1985; 20(1):80-4. PubMed ID: 3877562
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous mouse erythrocyte-rosette formation in chronic lymphocytic leukaemia.
Kuhlein E; Laurent G; Rigal F; Delsol G; Pris J; Ducos J
Clin Exp Immunol; 1982 Feb; 47(2):389-95. PubMed ID: 6978782
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexes and the prognosis of acute myeloid leukemia.
Carpentier NA; Fiere DM; Schuh D; Lange GT; Lambert PH
N Engl J Med; 1982 Nov; 307(19):1174-80. PubMed ID: 6956807
[TBL] [Abstract][Full Text] [Related]
20. Circulating immune complexes in chronic myeloid leukemia patients at various stages of the disease.
Saranath D; Advani S; Gangal S
Leuk Res; 1983; 7(6):771-7. PubMed ID: 6607388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
